LC-MS/MS analysis of differentially expressed glioblastoma membrane proteome reveals altered calcium signaling and other protein groups of regulatory functions

Ravindra Varma Polisetty, Poonam Gautam, Rakesh Sharma, H. C. Harsha, Sudha C. Nair, Manoj Kumar Gupta, Megha S. Uppin, Sundaram Challa, Aneel Kumar Puligopu, Praveen Ankathi, Aniruddh K. Purohit, Giriraj R. Chandak, Akhilesh Pandey, Ravi Sirdeshmukh

Research output: Contribution to journalArticle

54 Citations (Scopus)

Abstract

Membrane proteins play key roles in the development and progression of cancer. We have studied differentially expressed membrane proteins in glioblastoma multiforme (GBM), the most common and aggressive type of primary brain tumor, by high resolution LC-MS/MS mass spectrometry and quantitation by iTRAQ. A total of 1834 membrane proteins were identified with high confidence, of which 356 proteins were found to be altered by 2-fold change or more (198 up- and 158 down-regulated); 56% of them are known membrane proteins associated with major cellular processes. Mass spectrometry results were confirmed for representative proteins on individual specimens by immunohistochemistry. On mapping of the differentially expressed proteins to cellular pathways and functional networks, we notably observed many calcium-binding proteins to be altered, implicating deregulation of calcium signaling and homeostasis in GBM, a pathway also found to be enriched in the report (Dong, H., Luo, L., Hong, S., Siu, H., Xiao, Y., Jin, L., Chen, R., and Xiong, M. (2010) Integrated analysis of mutations, miRNA and mRNA expression in glioblastoma. BMC Syst. Biol. 4, 163) based on The Cancer Genome Atlas analysis of GBMs. Annotations of the 356 proteins identified by us with The Cancer Genome Atlas transcriptome data set indicated overlap with 295 corresponding transcripts, which included 49 potential miRNA targets; many transcripts correlated with proteins in their expression status. Nearly 50% of the differentially expressed proteins could be classified as transmembrane domain or signal sequence-containing proteins (159 of 356) with potential of appearance in cerebrospinal fluid or plasma. Interestingly, 75 of them have been already reported in normal cerebrospinal fluid or plasma along with other proteins. This first, in-depth analysis of the differentially expressed membrane proteome of GBM confirms genes/proteins that have been implicated in earlier studies, as well as reveals novel candidates that are being reported for the first time in GBM or any other cancer that could be investigated further for clinical applications.

Original languageEnglish (US)
JournalMolecular and Cellular Proteomics
Volume11
Issue number6
DOIs
StatePublished - Jun 1 2012
Externally publishedYes

Fingerprint

Calcium Signaling
Proteome
Glioblastoma
Calcium
Membranes
Membrane Proteins
Proteins
Cerebrospinal fluid
Atlases
MicroRNAs
Cerebrospinal Fluid
Mass Spectrometry
Neoplasms
Mass spectrometry
Genome
Genes
Molecular Sequence Annotation
Calcium-Binding Proteins
Plasmas
Deregulation

ASJC Scopus subject areas

  • Analytical Chemistry
  • Biochemistry
  • Molecular Biology

Cite this

LC-MS/MS analysis of differentially expressed glioblastoma membrane proteome reveals altered calcium signaling and other protein groups of regulatory functions. / Polisetty, Ravindra Varma; Gautam, Poonam; Sharma, Rakesh; Harsha, H. C.; Nair, Sudha C.; Gupta, Manoj Kumar; Uppin, Megha S.; Challa, Sundaram; Puligopu, Aneel Kumar; Ankathi, Praveen; Purohit, Aniruddh K.; Chandak, Giriraj R.; Pandey, Akhilesh; Sirdeshmukh, Ravi.

In: Molecular and Cellular Proteomics, Vol. 11, No. 6, 01.06.2012.

Research output: Contribution to journalArticle

Polisetty, RV, Gautam, P, Sharma, R, Harsha, HC, Nair, SC, Gupta, MK, Uppin, MS, Challa, S, Puligopu, AK, Ankathi, P, Purohit, AK, Chandak, GR, Pandey, A & Sirdeshmukh, R 2012, 'LC-MS/MS analysis of differentially expressed glioblastoma membrane proteome reveals altered calcium signaling and other protein groups of regulatory functions', Molecular and Cellular Proteomics, vol. 11, no. 6. https://doi.org/10.1074/mcp.M111.013565
Polisetty, Ravindra Varma ; Gautam, Poonam ; Sharma, Rakesh ; Harsha, H. C. ; Nair, Sudha C. ; Gupta, Manoj Kumar ; Uppin, Megha S. ; Challa, Sundaram ; Puligopu, Aneel Kumar ; Ankathi, Praveen ; Purohit, Aniruddh K. ; Chandak, Giriraj R. ; Pandey, Akhilesh ; Sirdeshmukh, Ravi. / LC-MS/MS analysis of differentially expressed glioblastoma membrane proteome reveals altered calcium signaling and other protein groups of regulatory functions. In: Molecular and Cellular Proteomics. 2012 ; Vol. 11, No. 6.
@article{8e158ab8c9004610ac116ac6f3ab746c,
title = "LC-MS/MS analysis of differentially expressed glioblastoma membrane proteome reveals altered calcium signaling and other protein groups of regulatory functions",
abstract = "Membrane proteins play key roles in the development and progression of cancer. We have studied differentially expressed membrane proteins in glioblastoma multiforme (GBM), the most common and aggressive type of primary brain tumor, by high resolution LC-MS/MS mass spectrometry and quantitation by iTRAQ. A total of 1834 membrane proteins were identified with high confidence, of which 356 proteins were found to be altered by 2-fold change or more (198 up- and 158 down-regulated); 56{\%} of them are known membrane proteins associated with major cellular processes. Mass spectrometry results were confirmed for representative proteins on individual specimens by immunohistochemistry. On mapping of the differentially expressed proteins to cellular pathways and functional networks, we notably observed many calcium-binding proteins to be altered, implicating deregulation of calcium signaling and homeostasis in GBM, a pathway also found to be enriched in the report (Dong, H., Luo, L., Hong, S., Siu, H., Xiao, Y., Jin, L., Chen, R., and Xiong, M. (2010) Integrated analysis of mutations, miRNA and mRNA expression in glioblastoma. BMC Syst. Biol. 4, 163) based on The Cancer Genome Atlas analysis of GBMs. Annotations of the 356 proteins identified by us with The Cancer Genome Atlas transcriptome data set indicated overlap with 295 corresponding transcripts, which included 49 potential miRNA targets; many transcripts correlated with proteins in their expression status. Nearly 50{\%} of the differentially expressed proteins could be classified as transmembrane domain or signal sequence-containing proteins (159 of 356) with potential of appearance in cerebrospinal fluid or plasma. Interestingly, 75 of them have been already reported in normal cerebrospinal fluid or plasma along with other proteins. This first, in-depth analysis of the differentially expressed membrane proteome of GBM confirms genes/proteins that have been implicated in earlier studies, as well as reveals novel candidates that are being reported for the first time in GBM or any other cancer that could be investigated further for clinical applications.",
author = "Polisetty, {Ravindra Varma} and Poonam Gautam and Rakesh Sharma and Harsha, {H. C.} and Nair, {Sudha C.} and Gupta, {Manoj Kumar} and Uppin, {Megha S.} and Sundaram Challa and Puligopu, {Aneel Kumar} and Praveen Ankathi and Purohit, {Aniruddh K.} and Chandak, {Giriraj R.} and Akhilesh Pandey and Ravi Sirdeshmukh",
year = "2012",
month = "6",
day = "1",
doi = "10.1074/mcp.M111.013565",
language = "English (US)",
volume = "11",
journal = "Molecular and Cellular Proteomics",
issn = "1535-9476",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "6",

}

TY - JOUR

T1 - LC-MS/MS analysis of differentially expressed glioblastoma membrane proteome reveals altered calcium signaling and other protein groups of regulatory functions

AU - Polisetty, Ravindra Varma

AU - Gautam, Poonam

AU - Sharma, Rakesh

AU - Harsha, H. C.

AU - Nair, Sudha C.

AU - Gupta, Manoj Kumar

AU - Uppin, Megha S.

AU - Challa, Sundaram

AU - Puligopu, Aneel Kumar

AU - Ankathi, Praveen

AU - Purohit, Aniruddh K.

AU - Chandak, Giriraj R.

AU - Pandey, Akhilesh

AU - Sirdeshmukh, Ravi

PY - 2012/6/1

Y1 - 2012/6/1

N2 - Membrane proteins play key roles in the development and progression of cancer. We have studied differentially expressed membrane proteins in glioblastoma multiforme (GBM), the most common and aggressive type of primary brain tumor, by high resolution LC-MS/MS mass spectrometry and quantitation by iTRAQ. A total of 1834 membrane proteins were identified with high confidence, of which 356 proteins were found to be altered by 2-fold change or more (198 up- and 158 down-regulated); 56% of them are known membrane proteins associated with major cellular processes. Mass spectrometry results were confirmed for representative proteins on individual specimens by immunohistochemistry. On mapping of the differentially expressed proteins to cellular pathways and functional networks, we notably observed many calcium-binding proteins to be altered, implicating deregulation of calcium signaling and homeostasis in GBM, a pathway also found to be enriched in the report (Dong, H., Luo, L., Hong, S., Siu, H., Xiao, Y., Jin, L., Chen, R., and Xiong, M. (2010) Integrated analysis of mutations, miRNA and mRNA expression in glioblastoma. BMC Syst. Biol. 4, 163) based on The Cancer Genome Atlas analysis of GBMs. Annotations of the 356 proteins identified by us with The Cancer Genome Atlas transcriptome data set indicated overlap with 295 corresponding transcripts, which included 49 potential miRNA targets; many transcripts correlated with proteins in their expression status. Nearly 50% of the differentially expressed proteins could be classified as transmembrane domain or signal sequence-containing proteins (159 of 356) with potential of appearance in cerebrospinal fluid or plasma. Interestingly, 75 of them have been already reported in normal cerebrospinal fluid or plasma along with other proteins. This first, in-depth analysis of the differentially expressed membrane proteome of GBM confirms genes/proteins that have been implicated in earlier studies, as well as reveals novel candidates that are being reported for the first time in GBM or any other cancer that could be investigated further for clinical applications.

AB - Membrane proteins play key roles in the development and progression of cancer. We have studied differentially expressed membrane proteins in glioblastoma multiforme (GBM), the most common and aggressive type of primary brain tumor, by high resolution LC-MS/MS mass spectrometry and quantitation by iTRAQ. A total of 1834 membrane proteins were identified with high confidence, of which 356 proteins were found to be altered by 2-fold change or more (198 up- and 158 down-regulated); 56% of them are known membrane proteins associated with major cellular processes. Mass spectrometry results were confirmed for representative proteins on individual specimens by immunohistochemistry. On mapping of the differentially expressed proteins to cellular pathways and functional networks, we notably observed many calcium-binding proteins to be altered, implicating deregulation of calcium signaling and homeostasis in GBM, a pathway also found to be enriched in the report (Dong, H., Luo, L., Hong, S., Siu, H., Xiao, Y., Jin, L., Chen, R., and Xiong, M. (2010) Integrated analysis of mutations, miRNA and mRNA expression in glioblastoma. BMC Syst. Biol. 4, 163) based on The Cancer Genome Atlas analysis of GBMs. Annotations of the 356 proteins identified by us with The Cancer Genome Atlas transcriptome data set indicated overlap with 295 corresponding transcripts, which included 49 potential miRNA targets; many transcripts correlated with proteins in their expression status. Nearly 50% of the differentially expressed proteins could be classified as transmembrane domain or signal sequence-containing proteins (159 of 356) with potential of appearance in cerebrospinal fluid or plasma. Interestingly, 75 of them have been already reported in normal cerebrospinal fluid or plasma along with other proteins. This first, in-depth analysis of the differentially expressed membrane proteome of GBM confirms genes/proteins that have been implicated in earlier studies, as well as reveals novel candidates that are being reported for the first time in GBM or any other cancer that could be investigated further for clinical applications.

UR - http://www.scopus.com/inward/record.url?scp=84862320289&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84862320289&partnerID=8YFLogxK

U2 - 10.1074/mcp.M111.013565

DO - 10.1074/mcp.M111.013565

M3 - Article

C2 - 22219345

AN - SCOPUS:84862320289

VL - 11

JO - Molecular and Cellular Proteomics

JF - Molecular and Cellular Proteomics

SN - 1535-9476

IS - 6

ER -